News

Seroquel XR is an antipsychotic medicine that contains quetiapine, used in patients with schizophrenia. Quetiapine attaches to several receptors on the surface of nerve cells and helps to

The milestone was triggered by Micromet’s achievement of pre-clinical for a BiTE antibody for the treatment of solid tumors. BiTE antibodies are designed to direct the body’s cytotoxic,

Simultaneously, Actelion Pharmaceuticals has launched Prospect registry, a multicenter, observational, US-based registry that will provide additional clinical experience on patients being treated with Epoprostenol for Injection. Epoprostenol for

The acquisition is expected to give Piramal access to key intellectual property developed by BSV for the manufacture of injectible anesthetic products including process based intellectual property and

The issued patent covers Mystic’s unit dose blister technology for packaging of drugs or biologics that have been freeze dried to powder form to improve stability, reduce the

The new patents are for the treatment of disorders associated with neurodegenarative diseases and these patents are valid until 2022, 2025 and 2025 respectively. Suven Life Sciences said

Dr Dixon brings 30 years of pharmaceutical development and commercial experience to the Orexigen board. His experience includes commercialisation strategy, new product launches and portfolio evaluation in cardiometabolic

The acquisition provides Abbott with a biologic intended to treat multiple sclerosis (MS) and compounds that complement its existing diverse oncology program. The new Abbott compounds include daclizumab,

Reportedly, the current CEO of Bayer HealthCare, Arthur Higgins, is expected to leave the company on April 30, 2010 . Werner Wenning, chairman of the board of management